Next Science Limited NXS.AX Stock
Next Science Limited Price Chart
Next Science Limited NXS.AX Financial and Trading Overview
| Next Science Limited stock price | 0.34 AUD |
| Previous Close | 0.53 AUD |
| Open | 0.56 AUD |
| Bid | 0.54 AUD x N/A |
| Ask | 0.54 AUD x N/A |
| Day's Range | 0.54 - 0.57 AUD |
| 52 Week Range | 0.48 - 1.08 AUD |
| Volume | 155.26K AUD |
| Avg. Volume | 80.58K AUD |
| Market Cap | 115.99M AUD |
| Beta (5Y Monthly) | 0.671418 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.11 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.77 AUD |
NXS.AX Valuation Measures
| Enterprise Value | 109.95M AUD |
| Trailing P/E | N/A |
| Forward P/E | -6.7500005 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.902617 |
| Price/Book (mrq) | 14.594595 |
| Enterprise Value/Revenue | 9.387 |
| Enterprise Value/EBITDA | -8.976 |
Trading Information
Next Science Limited Stock Price History
| Beta (5Y Monthly) | 0.671418 |
| 52-Week Change | -26.38% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.08 AUD |
| 52 Week Low | 0.48 AUD |
| 50-Day Moving Average | 0.62 AUD |
| 200-Day Moving Average | 0.69 AUD |
NXS.AX Share Statistics
| Avg. Volume (3 month) | 80.58K AUD |
| Avg. Daily Volume (10-Days) | 88.56K AUD |
| Shares Outstanding | 214.79M |
| Float | 101.1M |
| Short Ratio | N/A |
| % Held by Insiders | 51.46% |
| % Held by Institutions | 1.57% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -108.28% |
| Operating Margin (ttm) | -108.066% |
| Gross Margin | 78.11% |
| EBITDA Margin | -104.58% |
Management Effectiveness
| Return on Assets (ttm) | -60.44% |
| Return on Equity (ttm) | -134.91% |
Income Statement
| Revenue (ttm) | 11.71M AUD |
| Revenue Per Share (ttm) | 0.06 AUD |
| Quarterly Revenue Growth (yoy) | 25.19% |
| Gross Profit (ttm) | 9.15M AUD |
| EBITDA | -12249266 AUD |
| Net Income Avi to Common (ttm) | -12683312 AUD |
| Diluted EPS (ttm) | -0.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.11M AUD |
| Total Cash Per Share (mrq) | 0.02 AUD |
| Total Debt (mrq) | 1.22M AUD |
| Total Debt/Equity (mrq) | 15.18 AUD |
| Current Ratio (mrq) | 3.17 |
| Book Value Per Share (mrq) | 0.037 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11789770 AUD |
| Levered Free Cash Flow (ttm) | -6811286 AUD |
Profile of Next Science Limited
| Country | Australia |
| State | NSW |
| City | Chatswood |
| Address | The Zenith Building, Tower A |
| ZIP | 2067 |
| Phone | 61 2 8607 5126 |
| Website | https://www.nextscience.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the issues in human health caused by biofilms in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for postoperative wound; BACTISURE, a wound lavage that is used to remove biofilm; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, including microorganisms from wounds. The company was founded in 2012 and is headquartered in Chatswood, Australia.
Q&A For Next Science Limited Stock
What is a current NXS.AX stock price?
Next Science Limited NXS.AX stock price today per share is 0.34 AUD.
How to purchase Next Science Limited stock?
You can buy NXS.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Next Science Limited?
The stock symbol or ticker of Next Science Limited is NXS.AX.
Which industry does the Next Science Limited company belong to?
The Next Science Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Next Science Limited have in circulation?
The max supply of Next Science Limited shares is 291.7M.
What is Next Science Limited Price to Earnings Ratio (PE Ratio)?
Next Science Limited PE Ratio is now.
What was Next Science Limited earnings per share over the trailing 12 months (TTM)?
Next Science Limited EPS is -0.11 AUD over the trailing 12 months.
Which sector does the Next Science Limited company belong to?
The Next Science Limited sector is Healthcare.